Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The financing would be utilized by Edity to further develop its technology platform for intracellular delivery of therapeutic proteins utilizing immune cells in multiple therapeutic areas including gene editing, rare genetic disorders, oncology and inflammation.
Lead Product(s): Undisclosed
Therapeutic Area: Genetic Disease Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Dr. Reddy\'s Laboratories
Deal Size: $2.0 million Upfront Cash: $2.0 million
Deal Type: Financing December 30, 2023